Literature DB >> 8997605

Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

A Imperato1, M C Obinu, G Carta, M S Mascia, M A Casu, G L Gessa.   

Abstract

Changes in extracellular dopamine concentration in the ventral striatum during repeated amphetamine administration and over the first 7 days of withdrawal were studied by transversal microdialysis in freely moving rats. 2 days after fiber implantation rats were treated with either amphetamine (1.5 mg/kg i.p.) or saline every 12 h for 14 days. In amphetamine-treated rats, the baseline extracellular dopamine concentration, preceding the morning treatment, increased from 0.43 +/- 0.01 on day 1 up to 0.59 +/- 0.02 pmol/40 microliters sample on day 3 of treatment. Thereafter, dopamine fell rapidly on day 5(0.16 +/- 0.01 pmol/40 microliters) and remained at approximately the level reached on day 7(0.11 +/- 0.01 pmol/40 microliters) throughout the treatment and also over the 7 days of withdrawal. In contrast, in control rats, the extracellular dopamine concentration (0.40 +/- 0.01 pmol/40 microliters, on day 1) decreased progressively during the first days of treatment to reach a fairly stable value on day 4 (0.25 +/- 0.01 pmol/40 microliters sample). Thereafter, dopamine remained stable at this level throughout the remaining period of experimentation. Challenge with amphetamine (1.5 mg/kg i.p.) of animals treated with amphetamine for 10 days or withdrawn for 7 days produced a potentiated motor response compared to that in control rats but much less marked dopamine releasing effects. Dopamine synthesis in the ventral striatum, measured as L-dihydroxyphenylalanine formation after blockade of dihydroxyphenylalanine decarboxylase, was found to be reduced by approximately 60% after 2 weeks of amphetamine treatment and in animals withdrawn for 1 day or 7 days. These results indicate that repeated amphetamine treatment causes persistent inhibition of dopamine synthesis and release in the ventral striatum. Such inhibition may be a compensatory response to the repeated stimulation of postsynaptic dopamine receptors by the endogenously released dopamine and also the cause of postsynaptic sensitization to dopamine action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997605     DOI: 10.1016/s0014-2999(96)00742-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations.

Authors:  Julia Reinholz; Oliver Skopp; Caterina Breitenstein; Iwo Bohr; Hilke Winterhoff; Stefan Knecht
Journal:  Nutr Metab (Lond)       Date:  2008-12-01       Impact factor: 4.169

Review 3.  Neurobiology of aversive states.

Authors:  Erin N Umberg; Emmanuel N Pothos
Journal:  Physiol Behav       Date:  2011-05-01

4.  Omega-3 fatty acid deficiency impairs frontostriatal recruitment following repeated amphetamine treatment in rats: A 7 Tesla in vivo phMRI study.

Authors:  Robert K McNamara; Jennifer D Schurdak; Ruth H Asch; Diana M Lindquist
Journal:  Nutr Neurosci       Date:  2017-12-29       Impact factor: 4.994

Review 5.  Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.

Authors:  Hitoshi Morikawa; Richard A Morrisett
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

6.  Natural addiction: a behavioral and circuit model based on sugar addiction in rats.

Authors:  Bartley G Hoebel; Nicole M Avena; Miriam E Bocarsly; Pedro Rada
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

7.  Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.

Authors:  Lisa S Robison; Mala Ananth; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  J Neural Transm (Vienna)       Date:  2017-01-23       Impact factor: 3.575

8.  Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.

Authors:  Robin M Voigt; Amanda L Mickiewicz; T Celeste Napier
Journal:  Behav Brain Res       Date:  2011-07-12       Impact factor: 3.332

9.  Interference with AMPA receptor endocytosis: effects on behavioural and neurochemical correlates of amphetamine sensitization in male rats.

Authors:  Fiona Y Choi; Soyon Ahn; Yu Tian Wang; Anthony G Phillips
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

Review 10.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.